Guggenheim S&P 500 Equal Weight ETF  

(Public, NYSEARCA:RSP)   Watch this stock  
Find more results for RSP
97.47
+0.17 (0.17%)
Nov 17 - Close
NYSEARCA real-time data - Disclaimer
Currency in USD
Range 97.24 - 97.59
52 week 84.62 - 97.61
Open 97.24
Vol. 68,987.00
Mkt cap 14.38B
P/E     -
Div/yield 0.41/1.26
EPS -4.26
Shares 147.30M
Beta     -
Inst. own 40%

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin -344.29% 78.95%
Operating margin 78.18% 79.31%
EBITD margin - 79.31%
Return on average assets -6.21% 1.69%
Return on average equity -6.28% 1.71%
CDP Score - -

Address

9601 Blackwell Road Suite 500
Rockville, 20850
United States - Map
+1-301-2965100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Guggenheim S&P 500 Equal Weight ETF, formerly Rydex S&P 500 Equal Weight ETF, seeks to replicate as closely as possible, the daily performance of the S&P 500 Equal Weight Index (the Index). The Index is a capitalization-weighted index covering 500 industrial, utility, transportation and financial companies of the United States markets (mostly NYSE Euronext issues). The Index utilizes quarterly rebalancing to maintain its equal-weight stance. Under normal circumstances, the Fund will invest at least 90% of its net assets, plus any borrowing for investment purposes, in the equity securities (and derivatives thereof) included in the Index. The Fund invests in sectors, such as materials, telecommunication services, financials, consumer discretionary, information technology, industrials, healthcare, energy, consumer staples and utilities. Security Investors, LLC, which operates under the name Rydex Investments, serves as the investment adviser of the Fund.

Officers and directors

Richard M. Goldman President, Trustee
Age: 50
Bio & Compensation  - Reuters
Joanna M. Haigney Chief Compliance Officer
Age: 46
Bio & Compensation  - Reuters
Michael P. Byrum Vice President
Age: 46
Bio & Compensation  - Reuters
Kieth Fletcher Vice President
Bio & Compensation  - Reuters